Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells
Open Access
- 29 June 2001
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 276 (26), 23763-23768
- https://doi.org/10.1074/jbc.m102397200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Synergistic, p160 Coactivator-dependent Enhancement of Estrogen Receptor Function by CARM1 and p300Journal of Biological Chemistry, 2000
- RAC‐3 is a NF‐κB coactivatorFEBS Letters, 2000
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressorNature, 1995
- Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogueCancer Letters, 1995
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975